COSMIC-3D provides structural perspectives on cancer genetics for drug discovery
- PMID: 30158682
- PMCID: PMC6159874
- DOI: 10.1038/s41588-018-0214-9
COSMIC-3D provides structural perspectives on cancer genetics for drug discovery
Abstract
COSMIC-3D is a comprehensive integration of cancer mutations with protein structure across the human genome and structural proteome, seeking to support the identification and characterisation of protein targets for novel drug design in precision oncology. As an interactive system to explore cancer mutations in three-dimensions, COSMIC-3D is designed to enable a greater understanding of the functional impact of mutations, generate new hypotheses on which mutations are cancer drivers, and provide new opportunities for addressing these mutations pharmaceutically. This combination of genetics, structural proteomics, and drug development, can be best described as “mutation-guided drug design”.
Conflict of interest statement
Competing Financial Interests Statement
COSMIC-3D uses data and systems infrastructure from the COSMIC database group, which is partly funded from Wellcome Trust charitable funds together with sales of licenses to for-profit enterprises. H.K.S. and M.L.V. are employed by Astex Pharmaceuticals.
Figures

References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials